Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Atsushi Sakamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, National Center for Child Health and Development (NCCHD), Tokyo, Japan. Hauptthemen laut MEDLINE: Blood Platelets, Hemorrhage, DiGeorge Syndrome. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, The Grant of National Center for Child Health and Development.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
The deletion region of 22q11.2 deletion syndrome (22q11.2DS) contains a gene encoding glycoprotein Ibβ (GPIbβ), which is required to express the GPIb/IX/V complex on the platelet surface. Therefore, patients with 22q11.2DS may have congenital platelet disorders. However, information is limited on platelets and bleeding symptoms. In this study, we investigated clinical information, including bleeding symptoms, platelet counts, and GPIb expression levels in children and adolescents/adults with 22q11.2DS. Procedure Thirty‐two patients with 22q11.2DS were enrolled in a prospective cohort study between 2022 and 2023 at outpatient clinics within our institute.
Results
The median platelet counts in adolescents/adults with 22q11.2DS were significantly lower than those in children ( p < .0001). A gradual decrease was found along with increasing age ( p = .0006). Values of median GPIb expression on platelet surfaces (66% in children and 70% in adolescents/adults) were significantly lower than those in healthy controls ( p < .0001 and p = .0002). Bleeding symptoms included surgery‐related bleeding (52%), purpura (31%), and epistaxis (22%); most of them were minor. The median International Society on Thrombosis and Hemostasis bleeding assessment tool score was not significantly different between children and adolescents/adults ( p = .2311).
Conclusion
Although there was an age‐related decrease in platelet count and a disease‐related decrease in GPIb expression, no difference in bleeding symptoms was found between children and adolescents/adults. 22q11.2DS overall had minor bleeding symptoms in daily life, and the disease had little effect on spontaneous bleeding. However, some patients had major bleeding events; further accumulation of data on hemostasis during surgery and trauma is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
- Center for Postgraduate Education and Training, NCCHD, Tokyo, Japan.
- Department of Human Genetics, NCCHD, Tokyo, Japan.
- Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.
- Department of Genome Medicine, NCCHD, Tokyo, Japan.
- Division of Plastic Surgery, NCCHD, Tokyo, Japan.
ORCID-Profile: Atsushi Sakamoto
Förderung
- Japan Agency for Medical Research and Development
- The Grant of National Center for Child Health and Development
Zitieren
APA
Sakamoto, A., Uchiyama, T., Futatsugi, R., Ohara, O., Iguchi, A., Kaname, T., Hikosaka, M., Ono, H., Kunishima, S., Ito, S., & Ishiguro, A. (2024). Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31292
Vancouver
Sakamoto A, Uchiyama T, Futatsugi R, Ohara O, Iguchi A, Kaname T, et al. Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31292
BibTeX
@article{Sakamoto2024,
author = {Sakamoto, Atsushi and Uchiyama, Toru and Futatsugi, Ryohei and Ohara, Osamu and Iguchi, Akihiro and Kaname, Tadashi and Hikosaka, Makoto and Ono, Hiroshi and Kunishima, Shinji and Ito, Shuichi and Ishiguro, Akira},
title = {Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31292}
}
EUVIMED